[1] 史珣贝, 戴春富.  颞骨恶性肿瘤临床诊疗的现状[J]. 中华耳科学杂志, 2019, 17(3): 311-316.   doi: 10.3969/j.issn.1672-2922.2019.03.007
Shi JB, Dai CF.  Current opinions on clinical diagnosis and treatment of temporal bone malignancy[J]. Chin J Otology, 2019, 17(3): 311-316.   doi: 10.3969/j.issn.1672-2922.2019.03.007
[2] 程乐, 戴艳红, 徐新运.  内淋巴囊肿瘤临床、影像、病理和免疫组化分析[J]. 医学影像学杂志, 2012, 22(6): 1043-1045.   doi: 10.3969/j.issn.1006-9011.2012.06.058
Cheng L, Dai YH, Xu XY.  The clinical, radiological, pathological and immunohistochemical features of endolymphatic sac tumors[J]. J Med Imaging, 2012, 22(6): 1043-1045.   doi: 10.3969/j.issn.1006-9011.2012.06.058
[3] Alkhotani A, Butt B, Khalid M, et al.  Endolymphatic sac tumor at the cerebellopontine angle: a case report and review of literature[J]. Int J Surgery Case Reports, 2019, 58: 162-166.   doi: 10.1016/j.ijscr.2019.04.032
[4] Hassard AD, Boudreau SF, Cron CC.  Adenoma of the endolymphatic sac[J]. J Otolaryngol, 1984, 13(4): 213-216.
[5] Heffner DK.  Low-Grade adenocarcinoma of probable endolymphatic sac origin. A clinicopathologic study of 20 cases[J]. Cancer, 1989, 64(11): 2292-2302.   doi: 10.1002/1097-0142(19891201)64:11<2292::aid-cncr2820641119>3.0.co;2-#
[6] 郝瑾, 许丽萍, 鲜军舫, 等.  内淋巴囊瘤的临床和VHL基因突变分析研究[J]. 中华耳科学杂志, 2018, 16(5): 651-658.   doi: 10.3969/j.issn.1672-2922.2018.05.012
Hao J, Xu LP, Xian JF, et al.  Clinical and VHL gene mutation analysis of endolymphatic sac tumor[J]. Chin J Otology, 2018, 16(5): 651-658.   doi: 10.3969/j.issn.1672-2922.2018.05.012
[7] 岳云龙, 陈孝柏, 金延方.  内淋巴囊肿瘤的影像学表现(附两例报告并文献复习)[J]. 临床放射学杂志, 2007, 26(9): 869-871.   doi: 10.3969/j.issn.1001-9324.2007.09.007
Yue YL, Chen XB, Jin YF.  Imaging manifestations of endolymphatic sac tumor (with two reports and literature review)[J]. J Clin Radiology, 2007, 26(9): 869-871.   doi: 10.3969/j.issn.1001-9324.2007.09.007
[8]

Jackler RK, Driscoll CLW. Tumors of the ear and temporal bone[M]. Philadelphia: Lippincott Williams and Wilkins, 2000: 156–171.

[9] Lo WW, Applegate LJ, Carberry JN, et al.  Endolymphatic sac tumors: radiologic appearance[J]. Radiology, 1993, 189(1): 199-204.   doi: 10.1148/radiology.189.1.8372194
[10] Mendenhall WM, Suárez C, Skálová A, et al.  Current treatment of endolymphatic sac tumor of the temporal bone[J]. Adv Ther, 2018, 35(7): 887-898.   doi: 10.1007/s12325-018-0730-0
[11] 韩冬艳, 付慧君, 何燕燕, 等.  内淋巴囊肿瘤临床病理分析及文献复习[J]. 诊断学理论与实践, 2018, 17(6): 711-714.   doi: 10.16150/j.1671-2870.2018.06.016
Han DY, Fu HJ, He YY, et al.  Clinicopathological analysis and literature review of endolymphatic sac tumor[J]. J Diagn Concept Pract, 2018, 17(6): 711-714.   doi: 10.16150/j.1671-2870.2018.06.016
[12] 傅海燕, 王家耀.  内淋巴囊肿瘤四例临床病理观察及鉴别诊断[J]. 中华肿瘤防治杂志, 2014, 21(19): 1553-1556.   doi: 10.16073/j.cnki.cjcpt.2014.19.017
Fu HY, Wang JY.  Clinicopathological observation and differential diagnosis of four cases of endolymphatic sac tumor[J]. Chin J Cancer Prevent Treat, 2014, 21(19): 1553-1556.   doi: 10.16073/j.cnki.cjcpt.2014.19.017
[13] Andrade NN, Mathai PC, Kamil R, et al.  Inflammatory myofibroblastic tumour: a case report and a clinical update[J]. J Oral Biol Craniofac Res, 2017, 7(3): 219-222.   doi: 10.1016/j.jobcr.2017.09.005